Cargando…
Long-Term Remission of Acquired Von-Willebrand's Disease and Platelet Dysfunction after High-Dose Melphalan in a Patient with Multiple Myeloma
Background: Autologous stem cell transplantation is considered a standard of care treatment in eligible patients with multiple myeloma, but puts the patient at high risk for infections and bleeding complications. Acquired von-Willebrand's disease (AVWD) and acquired platelet dysfunction are rar...
Autores principales: | Stratmann, Jan, Gundermann, Stefan, Geisen, Christof, Dukat, Alexandra, Miesbach, Wolfgang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences, Hematology-Oncology and Stem Cell Transplantation Research Center
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557967/ https://www.ncbi.nlm.nih.gov/pubmed/31205622 |
Ejemplares similares
-
Prospective Evaluation of the Pre-, Intra-, and Postoperative Kinetics of ADAMTS-13, von Willebrand Factor, and Interleukin-6 in Vascular Surgery
por: Häußler, Katja Susanne, et al.
Publicado: (2020) -
Platelet Secretion Defects and Acquired von Willebrand Syndrome in Patients With Ventricular Assist Devices
por: Geisen, Ulrich, et al.
Publicado: (2018) -
Endothelial Function in Patients With Von Willebrand Disease
por: Noone, Stephanie, et al.
Publicado: (2021) -
Of von Willebrand factor and platelets
por: Bryckaert, Marijke, et al.
Publicado: (2014) -
Is gingival bleeding a symptom of type 2 and 3 von Willebrand disease?
por: Epping, Lisa, et al.
Publicado: (2018)